+++
title = "NU Skin Enterprises Inc. Showcases Strong Quarterly Performance and Strategic Growth Initiatives"
date = "2025-08-08T21:00:18Z"
draft = false
summary = "NU Skin Enterprises Inc. reports impressive quarterly results and outlines strategic initiatives, including expansion into India and the launch of an AI-powered wellness device, positioning the company for future growth."
description = "Stonegate Capital Partners covers Skin Enterprises Inc.'s strong Q2 performance, strategic growth, and future market expansion plans."
source_link = "https://stonegateinc.reportablenews.com/pr/stonegate-capital-partners-initiates-coverage-on-nu-skin-enterprises-inc-nyse-nus"
enclosure = "https://cdn.newsramp.app/reportable/newsimage/ff3766903edd5ada786cc3cac1e22bca.png"
article_id = 143113
feed_item_id = 18414
qrcode = "https://cdn.newsramp.app/reportable/qrcode/258/8/flaxASC6.webp"
source = "Reportable"
+++

<p>NU Skin Enterprises Inc. (NYSE: NUS) has recently been highlighted by Stonegate Capital Partners for its outstanding quarterly performance and strategic growth initiatives. The company reported revenue, adjusted Net Income, and adjusted EPS of $386.1M, $21.1M, and $0.43, respectively, with revenue reaching the high end of its guidance range. A standout segment, Rhyz Manufacturing, achieved a 17% year-over-year revenue growth, while EPS significantly exceeded guidance.</p><p>The company's gross margin for the quarter was 68.8%, showing a quarter-over-quarter expansion of 106 bps from 1Q25. This improvement is credited to NU Skin's dedication to revenue growth and operational optimization, resulting in a 103.5% year-over-year growth in adjusted Net Income. Stonegate Capital Partners remains optimistic about NU Skin's potential for continued margin expansion and its strong positioning for the upcoming quarter.</p><p>NU Skin is currently advancing two key strategic initiatives aimed at driving growth. The first involves expanding into India, with pre-opening activities planned for 4Q25 and a full launch expected by mid-2026. The second initiative is the introduction of the Prysm iO wellness device, an AI-powered tool designed to offer personalized product recommendations, which is expected to significantly enhance the company's product offerings and energize its brand representatives and sales leaders.</p><p>Despite experiencing a year-over-year decrease in sales leaders, paid affiliates, and customers, NU Skin reported a remarkable 107% revenue growth in Latin America, thanks to its scalable digital-first model. The company's financial health is robust, with $264.2M in cash on hand and achieving a net cash position ahead of schedule, providing the necessary flexibility to execute its strategic initiatives effectively.</p><p>Following a strong performance in the quarter, NU Skin has adjusted its FY25 revenue guidance to $1.48B to $1.55B and raised its adjusted EPS guidance to $1.15 to $1.35. Stonegate Capital Partners has valued NU Skin at a forward Price to Adj. EPS of 5.2x, suggesting a valuation range of $10.95 to $17.21 per share. For more information on NU Skin's performance and strategic initiatives, visit <a href='https://www.nuskin.com' rel='nofollow' target='_blank'>https://www.nuskin.com</a>.</p>